BMI1P1

Across TCGA pan-cancer cohorts, BMI1P1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated BMI1P1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher BMI1P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BMI1P1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and ESCA show a favorable association.

STAD, OV, and SKCM are the cancer types where BMI1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.217	0.447	.003	99	view →
OV	OS	Tertile	All	0.194	0.328	.018	36	view →
SKCM	OS	Tertile	III,IV	1.000	0.667	.020	27	view →
ESCA	OS	Tertile	III,IV	0.761	0.352	.026	21	view →
THCA	DFS	Tertile	II,III,IV	0.145	0.794	.001	18	view →
UCS	OS	Tertile	All	0.235	0.598	.014	18	view →
ACC	OS	Tertile	III,IV	0.189	0.757	<.001	18	view →
MESO	OS	Tertile	All	0.169	0.556	.043	9	view →
LUAD	OS	Tertile	II,III,IV	0.300	0.593	.029	9	view →
KIRC	DFS	Tertile	All	0.461	0.634	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

BMI1P1–STAD (OS)

Open the STAD breakdown →